Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2012
08/07/2012US8236851 Dispersed in a polymer; feeding to animals to prevent microbial infection
08/07/2012US8236756 Prodrugs cleavable by CD26
08/07/2012US8236753 RAP variants for drug delivery and methods of use thereof
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236351 Tamper-resistant oral opioid agonist formulations
08/07/2012US8236345 Composition and use
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236333 Active agent delivery and/or odor retentive composition and methods of use thereof
08/07/2012US8236328 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
08/07/2012US8236311 Antibodies against clostridium difficile toxins and uses thereof
08/07/2012CA2606861C Stable nanoparticle formulations
08/07/2012CA2564763C Hydrogen peroxide-based skin disinfectant
08/07/2012CA2559755C Dietary supplement and method for treating digestive system-related disorders
08/07/2012CA2536567C Pharmaceutical and cosmetic formulations for treating fingernails
08/07/2012CA2529475C Medicament sustained-release particles and method for preparing the same
08/07/2012CA2524258C Carrier complexes comprising cationic peptides for delivering molecules to cells
08/07/2012CA2509365C Compositions and methods of delivery of pharmacological agents
08/07/2012CA2489270C A method of treating human skin and a skin care composition for use in such a method
08/07/2012CA2461708C Delivery system for biological component
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2430557C Highly branched soluble glucose polymers and process of obtaining same
08/07/2012CA2429384C Concatameric immunoadhesion
08/07/2012CA2217251C Enhancing and stabilizing agent of the activity of bifidus factor
08/02/2012WO2012103421A1 Adjuvant nanoemulsions with crystallisation inhibitors
08/02/2012WO2012103040A1 Paraben compositions
08/02/2012WO2012103039A1 Surfactant compositions
08/02/2012WO2012103016A2 Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same
08/02/2012WO2012103011A1 Stable silver oxide formulations
08/02/2012WO2012102936A1 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
08/02/2012WO2012102861A1 Polymer - active agent conjugates
08/02/2012WO2012102538A2 Dry syrup composition
08/02/2012WO2012102364A1 Composition containing polyunsaturated fatty acid
08/02/2012WO2012102363A1 Drug delivery system and use of same
08/02/2012WO2012102362A1 Pharmaceutical composition containing drug having poor water solubility
08/02/2012WO2012102242A1 Hydrous adhesive patch
08/02/2012WO2012102210A1 Gel composition and use thereof
08/02/2012WO2012101309A1 Peptide-functionalised nanoliposomes
08/02/2012WO2012101235A1 Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
08/02/2012WO2012101124A1 Leptin derivatives
08/02/2012WO2012101016A1 Testosterone formulations
08/02/2012WO2012100590A1 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof
08/02/2012WO2012100408A1 Dextrin inclusion complex, preparation method thereof and pharmaceutical formulation comprising said inclusion complex
08/02/2012WO2012100366A1 Liposome and personal care composition comprising thereof
08/02/2012WO2012100346A1 Antibodies selective for cells presenting egfr at high density
08/02/2012WO2012068076A3 Pharmaceutical formulations containing soluble drugs
08/02/2012WO2012065060A3 Gas-filled microbubbles and systems for gas delivery
08/02/2012WO2012017349A3 Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
08/02/2012WO2011141685A3 Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
08/02/2012US20120196941 Absorption enhancers for drug administration
08/02/2012US20120196940 Pharmaceutical formulations
08/02/2012US20120196873 Stabilization of amorphous drugs using sponge-like carrier matrices
08/02/2012US20120196843 Compositions containing topical-active agents and pentyleneglycol
08/02/2012US20120196807 Kidney-targeting drug delivery agent comprising recombinant gelatin
08/02/2012US20120195967 Silk-based drug delivery system
08/02/2012US20120195951 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
08/02/2012US20120195940 Nanolipidic Particles
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195931 Polychlorinated biphenyls and squalene-containing adjuvants
08/02/2012US20120195877 Degradable composite material containing chitin or chitosan
08/02/2012US20120195846 Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
08/02/2012US20120195832 Process for producing an injectable medicament preparation
08/02/2012US20120195826 Injectable biomaterial
08/02/2012CA2825683A1 Leptin derivatives
08/02/2012CA2825417A1 Liposome and personal care composition comprising thereof
08/02/2012CA2825255A1 Antibodies selective for cells presenting egfr at high density
08/02/2012CA2825023A1 Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
08/02/2012CA2824941A1 Testosterone formulations
08/02/2012CA2824766A1 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
08/01/2012EP2481819A1 Cross flow filtration in the production of stabilized influenza vaccine compositions
08/01/2012EP2481710A1 Polymer-coated ferrite microparticles and production method for same
08/01/2012EP2481429A2 MMP Activated Vascular Disrupting Agents
08/01/2012EP2481428A2 MMP activated vascular disrupting agents
08/01/2012EP2481427A1 Folate-Tubulysin conjugates
08/01/2012EP2481426A1 Crosslinked polymers with the crosslinker as therapeutic for sustained release
08/01/2012EP2481416A1 Eye drops
08/01/2012EP2481401A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
08/01/2012EP2481400A1 Oral controlled release compositions comprising vitamin D compound and waxy carrier
08/01/2012EP2481399A1 Sustained drug delivery system
08/01/2012EP2481398A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects
08/01/2012EP2481396A2 Oxaliplatin nanoparticles and method for preparing same
08/01/2012EP2480578A2 Polypeptide modification
08/01/2012EP2480287A2 Dry powder combination of tiotropium
08/01/2012EP2480257A2 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/01/2012EP2480256A2 Chemically amplified response strategies for medical sciences
08/01/2012EP2480249A1 Use of plasmin for the treatment of filtration failure after trabeculectomy
08/01/2012EP2480234A2 Sustained release composition of ranolazine
08/01/2012EP2480226A2 Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
08/01/2012EP2480225A2 Dermal formulations of dp2 receptor antagonists
08/01/2012EP2480211A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
08/01/2012EP2480207A2 Micelle encapsulation of therapeutic agents
08/01/2012EP2480205A1 Injectable aqueous ophthalmic composition and method of use therefor
08/01/2012EP2480197A2 Formulations comprising triptan compounds
08/01/2012EP2257624B9 Methods and compositions
08/01/2012EP2206519B1 Medicinal preparation for oral administration
08/01/2012EP2127646B1 Agent for relief or prevention of xerostomia
08/01/2012EP1871423B1 Nanoparticle/active ingredient conjugate
08/01/2012EP1853310B1 Anti a beta antibody formulation
08/01/2012EP1830816B1 Solid dosage form comprising proton pump inhibitor and suspension made thereof
08/01/2012EP1806152B1 Drug for external use and adhesive patch
1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 1712